Literature DB >> 4292882

Isolation and amino acid composition of human angiotensin I.

K Arakawa, M Nakatani, A Minohara, M Nakamura.   

Abstract

1. Angiotensin, the most powerful pressor substance known, suspected to be a causal substance in renal hypertension and previously isolated from animal sources, has now been isolated from human sources and the amino acid composition was analysed. 2. The procedures followed in the successful isolation of human angiotensin include: (a) preparation of stable materials to obtain maximum formation of human angiotensin; (b) a relatively selective adsorption of the formed angiotensin on Dowex 50W (X2); (c) gel filtration through Sephadex G-25; (d) cation-exchange chromatography on CM-cellulose; (e) anion-exchange gel filtration on DEAE-Sephadex A-25; (f) molecular-sieve chromatography through Bio-Gel P-2. 3. The homogeneity of the human angiotensin isolated was confirmed by paper and thin-layer chromatography and paper electrophoresis. 4. The biological activity observed indicates the substance isolated to be human angiotensin I. 5. The amino acid analysis suggested the following proportional composition: Asp, 1; Pro, 1; Val, 1; Ile, 1; Leu, 1; Tyr, 1; Phe, 1; His, 2; Arg, 1. This composition is similar to that of horse angiotensin I, i.e. isoleucine(5)-angiotensin I.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4292882      PMCID: PMC1271231          DOI: 10.1042/bj1040900

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  The purification of hypertensin.

Authors:  W S PEART
Journal:  Biochem J       Date:  1955-03-19       Impact factor: 3.857

2.  Angiotensin.

Authors:  I H PAGE; F M BUMPUS
Journal:  Physiol Rev       Date:  1961-04       Impact factor: 37.312

3.  NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS.

Authors:  R BOUCHER; R VEYRAT; J DE CHAMPLAIN; J GENEST
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

4.  Synthesis and pharmacology of the octapeptide angiotonin.

Authors:  F M BUMPUS; H SCHWARZ; I H PAGE
Journal:  Science       Date:  1957-05-03       Impact factor: 47.728

5.  The isolation of a hypertension.

Authors:  W S PEART
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

6.  Amino-acid sequence in a hypertensin.

Authors:  D F ELLIOTT; W S PEART
Journal:  Nature       Date:  1956-03-17       Impact factor: 49.962

7.  Species specificity in reaction between renin and angiotensinogen.

Authors:  K Arakawa; M Nakatani; M Nakamura
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

8.  The purification of hypertensin II.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

9.  The purification of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1954-10-01       Impact factor: 14.307

10.  Amino acid composition and electrophoretic properties of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1955-10-01       Impact factor: 14.307

View more
  5 in total

1.  Outstanding circulation research by Japanese scientists.

Authors:  Shigeru Saito
Journal:  J Anesth       Date:  2011-11-18       Impact factor: 2.078

2.  Signatures of Mechanically Interlocked Topology of Lasso Peptides by Ion Mobility-Mass Spectrometry: Lessons from a Collection of Representatives.

Authors:  Kevin Jeanne Dit Fouque; Hélène Lavanant; Séverine Zirah; Julian D Hegemann; Marcel Zimmermann; Mohamed A Marahiel; Sylvie Rebuffat; Carlos Afonso
Journal:  J Am Soc Mass Spectrom       Date:  2016-11-03       Impact factor: 3.109

3.  Chemical identity of tryptensin with angiotensin.

Authors:  K Arakawa; M Yuki; M Ikeda
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

4.  [Metabolism of angiotensin II during angiotensin infusion and following sodium depletion].

Authors:  H P Nast; U Walter; A Distler
Journal:  Klin Wochenschr       Date:  1975-07-01

5.  Effect of prolonged low-dose infusions of ile5-angiotensin ii on blood pressure, aldosterone and electrolyte excretion in sodium replete man.

Authors:  W Oelkers; M Schöneshöfer; G Schultze; B Bauer
Journal:  Klin Wochenschr       Date:  1978-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.